Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Website URL
Similar Companies1000
GT Medical Technologies
GT Medical Technologies, Inc. is a medical device company that focuses on improving the lives of patients with brain tumors.
Sector
Subsector
Location
total rounds
total raised
SPR Therapeutics
SPR Therapeutics provides non-opioid pain treatment options for chronic pain.
Sector
Subsector
Keywords
Location
total rounds
total raised
GV20 Oncotherapy
GV20 Oncotherapy is a healthcare company that develops medical biotechnologies for customized cancer treatment.
Sector
Subsector
Keywords
Location
total rounds
total raised
ElmediX
ElmediX develops semi-automated hyperthermal therapy system to improve pancreatic cancer treatment.
Sector
Subsector
Location
total rounds
total raised
Financials
Funding Rounds2
Number of Funding Rounds
Money Raised
Their latest funding was raised on 10.11.2022. Their latest investor OrbiMed. Their latest round Series A
OrbiMed
OrbiMed is a healthcare-focused investment firm managing approximately $5 billion in assets.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Action Potential Venture Capital
Action Potential Venture Capital invests in bioelectronic medicine and technology companies.
Sector
Subsector
Keywords
Location
count Of Investments
Co-Investors
Investors6
Number of lead investors
Number of investors
OrbiMed
OrbiMed is a healthcare-focused investment firm managing approximately $5 billion in assets.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Klaus Veitinger
Klaus Veitinger is currently a Venture Partner with OrbiMed and he served as Chairman of Promentis Pharmaceuticals from April 2008 until February 2014. During his prior 16-year pharmaceutical career, Klaus Veitinger held senior management positions in drug development, licensing and business development, strategic planning and M&A, as well as general management. Most recently Klaus Veitinger was a Member of the Executive Board of Schwarz Pharma AG and the Chief Executive Officer of Schwarz Pharma Inc. with responsibility for the U.S. and Asia businesses culminating in the ultimate sale of the Schwarz Group. Klaus Veitinger has served and currently serves on the boards of several private and public companies in the life sciences sector. For seven years he was a Director of PhRMA. Klaus Veitinger received his medical degree and his doctorate (Ph.D.) from the University of Heidelberg. He earned his M.B.A. at INSEAD in France.
current job
SV Health Investors
SV Health Investors is a leading healthcare and life sciences venture capital and growth equity firm.
Sector
Subsector
Location
count Of Investments
count Of Exists
Medtech Convergence Fund
The Medtech Convergence Fund (MCF) is a venture capital fund that supports the development of innovative medical technology companies.
Sector
Subsector
count Of Investments
People
Founders1
Vijay Agarwal
Vijay graduated from Neurosurgical Residency at Duke University Hospital in 2016. He then completed specialized complex brain tumor training with the best known neurosurgeons throughout the world. He has a keen interest in brain disease, has published extensively, and has presented his research across the country and abroad. Heavily involved with innovation from an early age while growing up in Silicon Valley, he has helped launch multiple medical device companies. Vijay has been an integral part of the success of these devices in all stages, from concept and design to testing, FDA approval, and human trials. Before Duke, Vijay helped launch a posterior dynamic stabilization device that is currently in human trials. He received his BS in Electrical and Biomedical Engineering from UCLA.
current job
organization founded
Vijay Agarwal
